Exalenz Bioscience Ltd

Exalenz Bioscience creates cutting-edge diagnostic and monitoring platforms, which analyze minute changes in a patients exhaled breath. Specializing in noninvasive H. pylori and liver function diagnostics, our patented BreathID technology delivers immediate results with industry leading specificity and sensitivity. The BreathID platform offers a user-friendly interface and a cost-effective clinical diagnostic solution that can be used in any clinical setting, including laboratories, hospitals, point-of-care and the ICU. Driven by excellence as our core value, Exalenz Bioscience is committed to creating innovative diagnostics for management and monitoring of a broad range of GI and liver disorders. We make testing convenient for...

Medical devices,13c substrates,breath testing,helicobacter pylori,liver impairment,ubt,and h. pylori

Exalenz bioscience ltd operates in the Medical equipment manufacturing industry.

Exalenz bioscience ltd's revenue is 11m - 100m

Exalenz bioscience ltd has 11 - 50 employees.